Our Team

Alexandre DeSeabra co-founded BioFactura and has over 25 years of experience in biotechnology. From bench-scale research to large-scale manufacturing, Mr. DeSeabra has worked with both microbial and mammalian systems producing a broad spectrum of biologics.

Alex Matschiner co-founded BioFactura and has served as Vice-President of Operations, COO and CFO. Mr. Matschiner has more than 20 years of industry experience in R&D, manufacturing, and facility design.

Darryl Sampey co-founded BioFactura in 2004 and as President and CEO manages all strategic and scientific endeavors of the Company including partnership/alliance building, fundraising, intellectual property maintenance, contract research and development, platform technology programs, and biopharmaceutical product development.

Darryl Sampey co-founded BioFactura in 2004 and as President and CEO manages all strategic and scientific endeavors of the Company including partnership/alliance building, intellectual property maintenance, contract research and development, platform technology programs, and biopharmaceutical product development.

Dr. Dominic Eisinger is a biotechnology chief commercial executive and entrepreneur who combines his scientific expertise with business, market, and customer insights to achieve sustained commercial impact and value.

Dr. Hausfeld serves as Chairman of the Board of BioFactura as well as Chief Medical Officer. He provides strategic perspectives and plans for the targeted deployment of resources, the designing of clinical trials, expanding business development within the Biotech and business communities, as well as monitoring financial and governance aspects.

Dr. Hausfeld serves as Chairman of the Board of BioFactura as well as Chief Medical Officer. He provides strategic perspectives and plans for the targeted deployment of resources, the designing of clinical trials, expanding business development within the Biotech and business communities, as well as monitoring financial and governance aspects.